We are live on ! Find out more
MIP

Marietta Investment Partners Portfolio holdings

AUM $582M
1-Year Est. Return 54.15%
This Fund
S&P 500
This Quarter Est. Return
-14.01%
1 Year Est. Return
+54.15%
3 Year Est. Return
+159.91%
5 Year Est. Return
+239.2%
10 Year Est. Return
+1,894.68%
AUM
$335M
AUM Growth
-$102M
Cap. Flow
-$28.9M
Cap. Flow %
-8.62%
Top 10 Hldgs %
32.71%
Holding
187
New
7
Increased
57
Reduced
59
Closed
18

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$6.65M
2
HSY icon
Hershey
HSY
+$6.13M
3
CI icon
Cigna
CI
+$5.79M
4
ALB icon
Albemarle
ALB
+$5.03M
5
TSN icon
Tyson Foods
TSN
+$2.94M

Sector Composition

Rank Sector Weight
1 Technology 24.51%
2 Healthcare 18.34%
3 Industrials 13.28%
4 Financials 12.9%
5 Consumer Staples 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.45T
$25.5M 7.6%
186,492
+1,065
+0.6% +$161K
MSFT icon
2
Microsoft
MSFT
$3.71T
$15.8M 4.71%
61,451
+175
+0.3% +$47.5K
TMO icon
3
Thermo Fisher Scientific
TMO
$219B
$12.5M 3.72%
22,950
+353
+2% +$194K
GNRC icon
4
Generac Holdings
GNRC
$13B
$8.81M 2.63%
41,853
+632
+2% +$155K
ULTA icon
5
Ulta Beauty
ULTA
$22B
$8.46M 2.52%
21,955
-30
-0.1% -$11.9K
HDB icon
6
HDFC Bank
HDB
$120B
$8.31M 2.48%
302,408
-88,596
-23% -$2.5M
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$4.24T
$8.29M 2.47%
76,080
+340
+0.4% +$40K
FANG icon
8
Diamondback Energy
FANG
$57.2B
$7.52M 2.24%
62,055
+8,250
+15% +$1.13M
MSCI icon
9
MSCI
MSCI
$41.4B
$7.45M 2.22%
18,074
-1,057
-6% -$460K
NVO
10
Novo Nordisk
NVO
$203B
$7.11M 2.12%
127,686
+1,372
+1% +$76.1K
MRK icon
11
Merck
MRK
$333B
$7.11M 2.12%
78,018
+75,024
+2,506% +$6.65M
CI icon
12
Cigna
CI
$73.9B
$7.08M 2.11%
26,887
+22,467
+508% +$5.79M
MA icon
13
Mastercard
MA
$495B
$6.87M 2.05%
21,789
+1,024
+5% +$353K
EW icon
14
Edwards Lifesciences
EW
$53.1B
$6.83M 2.04%
71,835
-2,375
-3% -$246K
POOL icon
15
Pool Corp
POOL
$7.21B
$6.6M 1.97%
18,803
+93
+0.5% +$36.9K
HSY icon
16
Hershey
HSY
$37B
$6.36M 1.89%
29,534
+28,122
+1,992% +$6.13M
BRK.B icon
17
Berkshire Hathaway Class B
BRK.B
$1.08T
$6.02M 1.79%
22,047
+59
+0.3% +$18.5K
NVDA icon
18
NVIDIA
NVDA
$5.45T
$5.88M 1.75%
387,710
-1,720
-0.4% -$32.5K
CNQ icon
19
Canadian Natural Resources
CNQ
$99.7B
$5.78M 1.72%
219,825
+13,277
+6% +$403K
AMD icon
20
Advanced Micro Devices
AMD
$823B
$5.55M 1.66%
72,649
+14,565
+25% +$1.36M
ASML icon
21
ASML
ASML
$704B
$4.99M 1.49%
10,488
+1,223
+13% +$683K
ALB icon
22
Albemarle
ALB
$16.1B
$4.71M 1.41%
+22,563
New +$5.03M
XOM icon
23
ExxonMobil
XOM
$663B
$4.69M 1.4%
54,756
PEP icon
24
PepsiCo
PEP
$192B
$4.47M 1.33%
26,845
+245
+0.9% +$41.2K
AME icon
25
Ametek
AME
$58.9B
$4.16M 1.24%
37,848
+101
+0.3% +$12.3K

Similar funds

Marietta Investment Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Marietta Investment Partners held 187 positions worth $335M, down 23% from $438M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marietta Investment Partners withdrew a net $28.9M in Q2 2022, closing 18 positions and reducing 59 holdings. Its most notable exit was Tractor Supply, an estimated $5.38M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Marietta Investment Partners opened a new position in Albemarle worth $4.71M.

  • Marietta Investment Partners's largest Q2 2022 buy was Albemarle: 22,563 shares worth $4.71M.
  • Marietta Investment Partners added most to Merck in Q2 2022, an estimated $6.65M increase.
  • Marietta Investment Partners's biggest Q2 2022 reduction was Freeport-McMoran, cutting an estimated $9.5M.
  • Marietta Investment Partners fully exited Tractor Supply in Q2 2022, selling an estimated $5.38M.
  • Marietta Investment Partners's ten largest holdings make up 33% of its $335M portfolio in Q2 2022.
  • Marietta Investment Partners opened 7 new positions and closed 18 in Q2 2022.
  • Marietta Investment Partners's portfolio value fell 23% quarter-over-quarter to $335M.

Based on Marietta Investment Partners's 13F filing for Q2 2022, filed 10 Aug 2022.